Navigation Links
Analysis does not support genetic test before use of anti-clotting drug
Date:12/27/2011

CHICAGO Although the U.S. Food and Drug Administration (FDA) has recommended that a certain type of genetic testing (for the genotype CYP2C19) be considered before prescribing the drug clopidogrel to identify individuals who may be less responsive to the medication, a review and analysis of previous studies did not find an overall significant association between the CYP2C19 genotype and cardiovascular events, according to a study in the December 28 issue of JAMA.

Clopidogrel is an antiplatelet drug used by approximately 40 million patients worldwide to treat or prevent atherothrombotic (blood clot from thickening of inner lining of arteries) events and after percutaneous coronary revascularization (such as balloon angioplasty). "Despite the overall benefit, some individuals may be less responsive to clopidogrel than others because clopidogrel is a prodrug activated by several enzymes, including CYP2C19, and common genetic variation in CYP2C19 alters enzyme activity," according to background information in the article. The American Heart Association and American College of Cardiologists have argued evidence is insufficient to support CYP2C19 genotype testing.

Michael V. Holmes, M.B.B.S., M.Sc., of University College London, and colleagues conducted a systematic review and meta-analysis to assess the strength and quality of evidence on the association of CYP2C19 genotype with responsiveness to clopidogrel. The researchers conducted a search of the medical literature and identified 32 studies that met criteria for inclusion. These included studies that reported clopidogrel metabolism, platelet reactivity or clinically relevant outcomes (cardiovascular disease [CVD] events and bleeding), and information on CYP2C19 genotype.

The 32 studies included 42,016 patients reporting 3,545 CVD events, 579 stent thromboses, and 1,413 bleeding events. Six studies were randomized trials ("effect-modification" design) and the remaining 26 repo
'/>"/>

Contact: Michael V. Holmes, M.B.B.S., M.Sc.
mvholmes@gmail.com
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. ORNL image analysis prowess advances retina research
2. First analysis of tumor-suppressor interactions with whole genome in normal human cells
3. Results of the PARTNER Trial Cohort A cost effectiveness analysis reported
4. New analysis from the Nurses Health Study: Association of alcohol with risk of breast cancer
5. Analysis reveals malaria, other diseases as ancient, adaptive and persistent foes
6. Psychopathic killers: Computerized text analysis uncovers the word patterns of a predator
7. IU analysis changing diagnosis and management of initial UTIs in young children
8. UBC researchers create more powerful lab-on-a-chip for genetic analysis
9. Localized reactive badger culling raises bovine tuberculosis risk, new analysis confirms
10. Novel analysis method organizes genomic cancer data
11. The Cancer Genome Atlas completes detailed ovarian cancer analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... New research1 presented at the European Society of Cardiology ... of cardiovascular disease (CVD) is not enough to motivate ... data from 188,139 users of HeartAge.me, a free online ... factors as their estimated ,heart age, to test the ... CVD are more likely to attend medical examinations and ...
(Date:9/2/2014)... biochemists have discovered a family of proteins that could ... a pathogenic bacterium that can cause more than 60,000 ... of biochemistry and molecular biophysics, and Kasra Ramyar, his ... is the cause of increasing common staph infections. Their ... the National Academy of Sciences , or PNAS ...
(Date:9/2/2014)... News) -- Many people believe that marijuana is not ... "As more people are able to obtain and consume ... use, people are less likely to perceive it as ... at Massachusetts General Hospital,s Center for Addiction Medicine, said ... that cannabis use can have significant consequences, and we ...
(Date:9/2/2014)... 2014 Healthcare professionals will be able ... oncology guidelines available at the point of care following ... National Comprehensive Cancer Network® (NCCN®). Information from ... guidelines in the content available from the clinical reference ... not-for-profit alliance of 25 of the world's leading cancer ...
(Date:9/2/2014)... key to more youthful immune function might already be ... the Journal of Leukocyte Biology ... mice had different responses to Mycobacterium tuberculosis ... reversed by ibuprofen. , "Inflammation in old age can ... Ph.D., a researcher involved in the work from the ...
Breaking Medicine News(10 mins):Health News:Family history of cardiovascular disease is not enough to motivate people to follow healthy lifestyle 2Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 3Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 4
... Opus Healthcare Solutions, Inc., a ... today that OpusMobility(R) runs on ... ) , (Logo: http://www.newscom.com/cgi-bin/prnh/20080325/LATU040LOGO ) Opus ... or Wi-Fi connections on all smart phone devices ...
... January 13, 2009 A benchmarking study ... evaluated contemporary hospital glycemic management in United ... are suboptimal and do not meet current American ... The retrospective cohort study was based upon a ...
... its annual Molecular Imaging Summit to introducing the new ... Hilton Clearwater Hotel, Clearwater, Fl. In part, the program ... Network, which was designed to facilitate cost-effective drug development ... 2, 3 and 4 therapeutics clinical trials. In addition, ...
... health care policyWASHINGTON, Jan. 13 The RAND ... policymakers and interested parties with a unique way ... consequences of health care reform proposals certain to ... beyond. COMPARE (Comprehensive Assessment of Reform Efforts) is ...
... ATLANTA, Jan. 13 Vendormate nearly tripled its customer,base ... in 42 states across the,U.S. in part because of ... help mitigate the risk of supply chain,interruptions. , ... and financial service,providers in particular are anxious about their ...
... Family,Services, Inc. No. 2851 on its annual ranking of ... marks the second consecutive year that,Access Family Services has ... the most,comprehensive look at the most important segment of ... whole, these companies represent,the backbone of the U.S. economy. ...
Cached Medicine News:Health News:OpusMobility(R) Clinical Information System Runs on Google G1 Smart Phone 2Health News:OpusMobility(R) Clinical Information System Runs on Google G1 Smart Phone 3Health News:Annual SNM MI summit introduces the clinical trials network 2Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 2Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 3Health News:RAND Launches Unique Tool to Evaluate Health Care Proposals 4Health News:Economic Uncertainty Fuels Vendormate Growth in 2008 2Health News:Access Family Services, Inc. Makes the List for the Second Year in a Row! Access Family Services 2008 Ranks No. 2851 on the Inc. 5000 With Three-Year Sales Growth of 128% 2
(Date:9/2/2014)... 2, 2014 According to ... Research "Latin America Home Healthcare Market (By Device ... Devices, Mobility Assist Devices and Medical Supplies; By ... Therapy and Unskilled Home Healthcare Services) - Industry ... - 2020" the Latin American Home Healthcare market ...
(Date:9/2/2014)... , Sept. 2, 2014   Santa Clara dentist ... a special promotion for Invisalign. Invisalign is an orthodontic ... wires. It is often the orthodontic treatment of choice ... and aesthetics of it. For a limited time, patients ... significant savings from the usual cost. This offer cannot ...
(Date:9/2/2014)...    - Los datos ... antitrombóticos no utilizados óptimamente para prevenir la apoplejía ... de GARFIELD-AF en el ESC CONGRESS 2014 ofrecen ... de pacientes en riesgo de sufrir apoplejía en ... Los datos de casi 12.500 pacientes reclutados en ...
Breaking Medicine Technology:Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 2Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 3Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 4Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 5Home Healthcare Market in Latin America Expected to Reach USD 17.5 Billion in 2020: Transparency Market Research 6Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 2Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 3Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 4Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 5Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 6Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 7Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 8Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 9Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 10Los datos sobre fibrilación atrial muestran agentes antitrombóticos no usados óptimamente para prevenir la apoplejía 11
... Oct. 6 According to Millennium Research Group ... intelligence, growth in the $2 billion US cardiac ... the expanded approval of Boston Scientific,s chronic resynchronization ... I and II patients. The New ...
... Oct. 6 e-MDs, an industry leader in ... (EHRs) and practice management (PM) solutions,  congratulates  the ... Family Medicine of Fort Collins, CO, for their ... of Excellence recipients.  The Healthcare Information and Management ...
Cached Medicine Technology:Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 2Positive Results From the MADIT-CRT Trial Support the Expanding Approval of Cardiac Resynchronization Therapy Defibrillators 3e-MDs Clients Win HIMSS Davies Awards of Excellence 2e-MDs Clients Win HIMSS Davies Awards of Excellence 3e-MDs Clients Win HIMSS Davies Awards of Excellence 4
Colloidal Gold Conjugated, Rabbit anti-goat IgG (H&L) - 12 OD...
Polyester ribbons (3) impregnated with different OD values of conjugated Protein A...
Polyester ribbon impregnated with conjugated Protein A - .50 OD per sq. cm....
Colloidal Gold Conjugated, Protein A - 12 OD...
Medicine Products: